MedTrace Logo

Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)

NCT02437409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2017-08-23

Study results available
· View outcomes & findings →

Summary

ARTESp is a prospective multicenter study in which the pREset thrombectomy system (phenox GmbH\* Germany) will be examined. The effectiveness, safety and the long-term success when using the pREset to treat acute occlusions of cerebral vessels will be analyzed.

\*German: "Gesellschaft mit beschränkter Haftung", limited liability company

Conditions

Interventions

DEVICE

pREset thrombectomy retriever

Interventional recanalization of acute cerebral vessel occlusions with the pREset thrombectomy system alone or in combination with intravenous or intraarterial thrombolytics (rt-PA).

Sponsors & Collaborators

  • Phenox GmbH

    lead INDUSTRY

Principal Investigators

  • Wolfgang Reith, Prof. · Universitätsklinikum des Saarlands

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-03-31
Completion
2015-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02437409 on ClinicalTrials.gov